[
  {
    "ts": null,
    "headline": "Janus Henderson Enterprise Fund Q4 2025 Portfolio Review",
    "summary": "Janus Henderson Enterprise Fund Q4 2025 commentary examines performance drivers for J.B. Hunt and Revolution Medicines, alongside headwinds for Constellation Software and CoStar Group.",
    "url": "https://finnhub.io/api/news?id=d579cdb7d519bdc02f714291acad30f867fd36457f8328fe41efb98118150368",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768851600,
      "headline": "Janus Henderson Enterprise Fund Q4 2025 Portfolio Review",
      "id": 138181613,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1441354501/image_1441354501.jpg?io=getty-c-w1536",
      "related": "CSGP",
      "source": "SeekingAlpha",
      "summary": "Janus Henderson Enterprise Fund Q4 2025 commentary examines performance drivers for J.B. Hunt and Revolution Medicines, alongside headwinds for Constellation Software and CoStar Group.",
      "url": "https://finnhub.io/api/news?id=d579cdb7d519bdc02f714291acad30f867fd36457f8328fe41efb98118150368"
    }
  }
]